Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow (2020 - 2025)

iSpecimen (ISPC) has 6 years of Net Cash Flow data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Net Cash Flow rose 649.33% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $1.0 million, up 206.47%, while the annual FY2024 figure was -$465258.0, 96.41% up from the prior year.
  • Net Cash Flow reached $2.2 million in Q3 2025 per ISPC's latest filing, up from -$192234.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $17.9 million in Q4 2021 and bottomed at -$11.5 million in Q1 2023.
  • Average Net Cash Flow over 5 years is -$742706.0, with a median of -$399389.0 recorded in 2024.
  • The widest YoY moves for Net Cash Flow: up 6967.86% in 2021, down 888.48% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at $17.9 million in 2021, then tumbled by 129.8% to -$5.3 million in 2022, then surged by 92.94% to -$377902.0 in 2023, then surged by 133.49% to $126554.0 in 2024, then skyrocketed by 1633.63% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $2.2 million in Q3 2025, -$192234.0 in Q2 2025, and -$1.1 million in Q1 2025.